Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial

BACKGROUND: Gastrectomy for gastric cancer is a significant cause of secondary exocrine pancreatic insufficiency. Pancreatic enzyme replacement therapy may influence nutritional status and quality of life after gastrectomy, but the pertinent clinical research to date remains controversial. A randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Catarci, Marco, Berlanda, Manuele, Grassi, Giovanni Battista, Masedu, Francesco, Guadagni, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906500/
https://www.ncbi.nlm.nih.gov/pubmed/28804801
http://dx.doi.org/10.1007/s10120-017-0757-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906500/
https://www.ncbi.nlm.nih.gov/pubmed/28804801
http://dx.doi.org/10.1007/s10120-017-0757-y

Ejemplares similares